Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Currently, tumour stage and grade are the cornerstone indicators of prognosis in bladder cancer. Refinements in histological assessment and new molecular markers are discussed. Evidence is reviewed supporting the notion of two separate molecular pathways to bladder cancer. Deletion of candidate tumour-suppressor genes is an early and common event in primary bladder cancer.


Journal article


Current Opinion in Urology

Publication Date





267 - 271